Vaccibody Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 75
Employees
  • Stock Symbol
  • VACC
Stock Symbol
  • Share Price
  • $8.14
  • (As of Thursday Closing)

Vaccibody General Information

Description

Vaccibody AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
OSL
Primary Office
  • Oslo Research Park
  • Gaustadalléen 21
  • 0349 Oslo
  • Norway
+47 22 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaccibody Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.14 $8.00 $4.72 - $11.08 $2.3B 287M 233K $0.53

Vaccibody Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,323,504 2,480,684
Revenue 217,054 215,000 0 16
EBITDA 176,360 181,057 (13,894) (8,039)
Net Income 146,442 149,774 (13,696) (7,834)
Total Assets 212,052 230,028 33,386 17,959
Total Debt 103 284 90 230
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vaccibody Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vaccibody‘s full profile, request access.

Request a free trial

Vaccibody Executive Team (13)

Name Title Board Seat Contact Info
Michael Engsig Chief Executive Officer
Lars Nielsen Chief Financial Officer
Agnete Fredriksen Ph.D Co-Founder & Chief Innovation & Strategy Officer
Mikkel Pedersen Chief Scientific Officer
Hans Tjeldflaat Finance Director
You’re viewing 5 of 13 executive team members. Get the full list »

Vaccibody Board Members (11)

Name Representing Role Since
000000 000 Self Chairman 000 0000
00000 000000000 00.0 Self Board Member 000 0000
000000000 0000000 Vaccibody Board Member 000 0000
00000 00000 Vaccibody Board Member 000 0000
000000 00000000 Sarsia Seed Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Vaccibody Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial